OLENDALIZUMAB
UNII 4971UQC7F3

Substance Identification & Data

This profile provides standardized clinical and technical data for Olendalizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4971UQC7F3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1337966-73-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

4971UQC7F3

CAS Registry Number

1337966-73-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

OLENDALIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C118441

National Cancer Institute reference terminology for clinical and research data.

INN ID

10037

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

ZZ-107

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Olendalizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LENDALIZUMAB

OLENDALIZUMAB

Common Names & Synonyms

IMMUNOGLOBULIN, ANTI-(HUMAN COMPLEMENT C5A) (HUMAN-MUS MUSCULUS ALXN1007 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS ALXN1007 .KAPPA.-CHAIN, DIMER

OLENDALIZUMAB [INN]

OLENDALIZUMAB [USAN]

OLENDALIZUMAB [WHO-DD]